Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gauthier, S. A.
Right arrow Articles by Weiner, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gauthier, S. A.
Right arrow Articles by Weiner, H. L.
Related Collections
Right arrow Prognosis
Right arrow Multiple sclerosis
NEUROLOGY 2007;68:2059-2065
© 2007 American Academy of Neurology

Predicting short-term disability in multiple sclerosis

S. A. Gauthier, DO, MPH, M. Mandel, PhD, C.R.G. Guttmann, MD, B. I. Glanz, PhD, S. J. Khoury, MD, R. A. Betensky, PhD and H. L. Weiner, MD

From Partners Multiple Sclerosis Center (S.A.G., B.I.G., S.J.K., H.L.W.) and Center of Neurological Imaging (C.R.G.G.), Brigham and Women's Hospital, Harvard Medical School; and Department of Biostatistics (M.M., R.A.B.), Harvard School of Public Health, Boston, MA.

Address correspondence and reprint requests to Dr Weiner, Partners Multiple Sclerosis Center, Brigham and Women's Hospital, 1 Brookline Place, Suite 225, Brookline, MA 02445 hweiner{at}rics.bwh.harvard.edu

Objective: To develop covariate specific short-term disability curves to demonstrate the probability of progressing by Expanded Disability Status Scale (EDSS) at semiannual visits.

Methods: Semiannual EDSS scores were prospectively collected in 218 relapsing-remitting (RR) and clinically isolated syndrome (CIS) patients as part of the Comprehensive Longitudinal Investigation of Multiple Sclerosis at the Brigham and Women's Hospital (CLIMB) study. Baseline brain parenchymal fraction (BPF) and T2 lesion volume were available on 205 patients. A partial proportional odds model determined the influence of covariates on the change in EDSS score at subsequent visits. A discrete second order Markov transitional model was fit and generated a probability matrix for each subject; the 6-month probabilities of EDSS change were graphically represented.

Results: The univariate analysis demonstrated the lowest baseline BPF quartile (OR 1.99; p = 0.0203) and the highest T2 lesion volume quartile (OR 2.19; p = 0.0130) were associated with progression in EDSS. Covariate specific disability curves demonstrated the effect of BPF and T2 lesion volume on short-term progression. In subjects with a 6-month EDSS of 2, the probability of a sustained progression of an EDSS of 3 within 3 years was 0.277 for a subject with low BPF and a high T2 lesion volume vs 0.055 for a subject with high BPF and a low T2 lesion volume.

Conclusions: Markov transitional models allow for the comparison of covariate specific short-term disability changes among groups of patients with multiple sclerosis.


Supported by the Nancy Davis Foundation.

Disclosure: The authors report no conflicts of interest.

Received June 1, 2006. Accepted in final form February 6, 2007.




This article has been cited by other articles:


Home page
BrainHome page
K. M. Zackowski, S. A. Smith, D. S. Reich, E. Gordon-Lipkin, B. A. Chodkowski, D. R. Sambandan, M. Shteyman, A. J. Bastian, P. C. van Zijl, and P. A. Calabresi
Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord
Brain, May 1, 2009; 132(5): 1200 - 1209.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. P. Thompson, K. Noyes, E. R. Dorsey, S. R. Schwid, and R. G. Holloway
Quantitative risk-benefit analysis of natalizumab
Neurology, July 29, 2008; 71(5): 357 - 364.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by AAN Enterprises, Inc.